CSL ( CSLLY) agreed to pay Alentis Therapeutics $355 million upfront as part of a global partnership to develop lixudebart, ...

OpenAI ( OPENAI) CEO Sam Altman said his company remains fundamentally divided with rival Anthropic ( ANTHRO) over how ...

VFLO currently presents a stronger value proposition, with a lower average P/E (15.8x) and greater alignment to AI and memory ...

Political pressure mounts on Fed’s Jerome Powell after watchdog report on HQ renovation—what it means for Fed independence, rates and markets.

Germane at the moment is NVDA's implied volatility profile. According to data from Option Research & Technology Services, the ...

The difference between GEICO’s costs and those of its competitors is a kind of moat that protects a valuable and ...

BNY Mellon U.S. Large Cap Core Equity ETF (BKLC) offers zero-fee exposure to large-cap U.S. equities, heavily concentrated in ...

VTG ETF review: low-cost intermediate Treasuries (5–6yr duration) with no credit risk, but rate sensitivity and inflation ...

Weyerhaeuser (WY) and Rayonier (RYN) look undervalued after share weakness, with attractive dividends and upside potential.

Mixed US stocks as weak jobs data and cooler inflation ease Fed fears, but long rates surge. Click here to read more on the ...

The MICVO oncology drug shows promising early data; dosage optimization is ahead. Click for more on PYXS stock.

Kimbell Royalty Partners is upgraded to Strong Buy after a record quarter, increased distributions, and two strategic ...